"Joy just said Behring gross margin at its(pandemic induced) low point. Ie. Will only improve from here."
If you want to quote company management, you really should do it properly with the full citation, instead of just selecting certain bits to relay to this forum.
Otherwise there's a risk that people might come to view you as a blinkered cheerleader for the stock. And you wouldn't want to create that impression, would you?
So, in the interests of balance, I'll include what both the CEO and CFO said in relation to Behring gross margins, which you omitted to mention, namely that while donor fees will ease, they are unlikely to go back to where they were before Covid.
Meaning that other levers will need to be found if the GP Margin is to be fully restored.
.
.
News: CSL UPDATE 1-CSL's half-year profit beats estimates on robust blood plasma collections, page-41
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$293.00 |
Change
2.260(0.78%) |
Mkt cap ! $141.5B | |||
| Open | High | Low | Value | Volume |
| $294.00 | $294.75 | $290.82 | $491.6M | 1.702M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 8192 | $292.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $293.06 | 12368 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |